Save time and get answers to complex questions with AI chat
Patent expiry trametinib?Patent tenofovir alafenamide gilead?When will latisse patent expire?Antiox mebendazole price?When will a generic version of xiaflex be available?
See the DrugPatentWatch profile for Repatha
I don’t have real-time stock data, but Repatha (evolocumab) has had intermittent shortages in the past due to manufacturing or supply-chain issues. To check current availability: - FDA Drug Shortages database (US): search for evolocumab or Repatha. - Amgen’s Repatha site or patient support line for latest supply updates and options. - Your local pharmacy or pharmacist, who can confirm current stock and any backorder plans. What to do if there’s a shortage: - Talk with your prescriber about alternatives or timing (e.g., switch to a different PCSK9 inhibitor if available, or consider other lipid-lowering therapies). - Possible alternatives to discuss with your doctor: - Alirocumab (Praluent) - Ezetimibe (Zetia) - Bempedoic acid (Nexletol) - Inclisiran (Leqvio) where available - Ensure ongoing statin therapy if appropriate, and ask about non-statin options or bridging strategies. - Check for patient assistance programs or insurance help if cost or access is an issue. If you tell me your country (and, if US, your state), I can point you to the most relevant official sources for current shortage status. If you’re about to run out or have high cardiovascular risk, contact your clinician promptly for a plan.
Other Questions About Repatha :